Choosing the control arm/standard of care in clinical trials

Share :
Published: 18 Sep 2022
Views: 1429
Dr Bishal Gyawali - Queen's University, Kingston, Canada

Dr Bishal Gyawali speaks to ecancer about the workshop at Choosing Wisely 2022 Mumbai, which focused on clinical trials.

His talk explored the control arm treatments in clinical trials for low-middle-income countries.

He concludes by stating that LMIC should be selective in spending resources only on those trials that are meaningful to their patients.